Cardiac muscle cells as good as progenitors for heart repair

October 22, 2015

Reports on stem cell therapies for post-heart attack tissue repair have described at best modest success. Most clinical trials have used bone marrow-derived cells, which are thought to promote the growth of new blood vessels in the damaged heart, but many of these studies have shown no benefit for the patient. A better alternative may be to use heart muscle cells (cardiomyocytes) or progenitor cells that can form both heart muscle and blood vessels for cell therapy. These can both be derived from human embryonic stem cells.

In a paper published October 22 in Stem Cell Reports, the journal of the International Society for Stem Cell Research, a study was described in which the authors compared how well human embryonic stem-cell derived cardiomyocytes or cardiovascular progenitors, compared with human bone marrow-derived cells in the repair of tissue damaged by heart attack in rats. The study showed that embryonic stem cell-derived cardiomyocytes and cardiovascular progenitors surpassed the healing power of bone marrow-derived cells.

A second finding of the study was that despite the cardiovascular progenitors' ability to differentiate into both blood vessels and heart muscle, there was no greater improvement in heart function compared to treatment with the more mature cardiomyocytes alone, suggesting that the more mature and stable heart muscle cells are a better option for future therapies and that they may well exceed the efficacy of bone marrow-derived cells in clinical studies.

"There's no reason to go back to more primitive cells [like cardiovascular progenitors] because they don't seem to have a practical advantage over more definitive cell types [cardiomyocytes] in which the risk for tumor formation is lower," says senior study author Charles Murry of the University of Washington, Seattle. "The other important finding is that both of these populations are far superior to bone marrow-derived cells. This work is a go signal that tells us to keep moving on to more promising and more powerful cell types in human trials."

The experiments, led by first authors Sarah Fernandes and James J.H. Chong, involved injecting the cells in the walls of the heart and measuring how well heart muscle tissue contracted in follow up test four weeks later. About 10 animals receiving each of the three treatment variables, and 10 controls receiving a non-therapeutic cell population, were included in the study. Injections were given 4 days after heart attacks had occurred in the rats, as interventions that are given later don't have as much impact.

James Chong, now an interventional cardiologist at the University of Sydney, added "We have recently had success in regenerating hearts of monkeys using a similar approach of transplanting embryonic stem cell-derived cardiomyocytes. The next goals will be to determine if these large animal experiments show similar improvements in cardiac function, and if so, to begin testing these cells in human patients."
This work was supported by the National Institutes of Health.

Stem Cell Reports, Fernandes and Chong et al.: "Comparison of Human Embryonic Stem Cell-Derived Cardiomyocytes, Cardiovascular Progenitors, and Bone Marrow Mononuclear Cells for Cardiac Repair"

Stem Cell Reports, published by Cell Press for the International Society for Stem Cell Research (@ISSCR), is a monthly open-access forum communicating basic discoveries in stem cell research, in addition to translational and clinical studies. The journal focuses on shorter, single-point manuscripts that report original research with conceptual or practical advances that are of broad interest to stem cell biologists and clinicians. For more information, please visit To receive media alerts for this or other Cell Press journals, please contact

Cell Press

Related Blood Vessels Articles from Brightsurf:

Biofriendly protocells pump up blood vessels
In a new study published today in Nature Chemistry, Professor Stephen Mann and Dr Mei Li from Bristol's School of Chemistry, together with Associate Professor Jianbo Liu and colleagues at Hunan University and Central South University in China, prepared synthetic protocells coated in red blood cell fragments for use as nitric oxide generating bio-bots within blood vessels.

Specific and rapid expansion of blood vessels
Upon a heart infarct or stroke, rapid restoration of blood flow, and oxygen delivery to the hypo perfused regions is of eminent importance to prevent further damage to heart or brain.

Flexible and biodegradable electronic blood vessels
Researchers in China and Switzerland have developed electronic blood vessels that can be actively tuned to address subtle changes in the body after implantation.

Lumpy proteins stiffen blood vessels of the brain
Deposits of a protein called ''Medin'', which manifest in virtually all older adults, reduce the elasticity of blood vessels during aging and hence may be a risk factor for vascular dementia.

Cancer cells take over blood vessels to spread
In laboratory studies, Johns Hopkins Kimmel Cancer Center and Johns Hopkins University researchers observed a key step in how cancer cells may spread from a primary tumor to a distant site within the body, a process known as metastasis.

Novel function of platelets in tumor blood vessels found
Scientists at Uppsala University have discovered a hitherto unknown function of blood platelets in cancer.

Blood vessels can make you fat, and yet fit
IBS scientists have reported Angiopoietin-2 (Angpt2) as a key driver that inhibits the accumulation of potbellies by enabling the proper transport of fatty acid into general circulation in blood vessels, thus preventing insulin resistance.

Brothers in arms: The brain and its blood vessels
The brain and its surrounding blood vessels exist in a close relationship.

Feeling the pressure: How blood vessels sense their environment
Researchers from the University of Tsukuba discovered that Thbs1 is a key extracellular mediator of mechanotransduction upon mechanical stress.

Human textiles to repair blood vessels
As the leading cause of mortality worldwide, cardiovascular diseases claim over 17 million lives each year, according to World Health Organization estimates.

Read More: Blood Vessels News and Blood Vessels Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to